Siddharth A Padia

Summary

Publications

  1. Chan K, Alessio A, Johnson G, Vaidya S, Kwan S, Monsky W, et al. Hepatotoxic Dose Thresholds by Positron-Emission Tomography After Yttrium-90 Radioembolization of Liver Tumors: A Prospective Single-Arm Observational Study. Cardiovasc Intervent Radiol. 2018;41:1363-1372 pubmed publisher
    ..The likelihood of toxicity exceeds 50% at a dose threshold of 54 Gy. ClinicalTrials.gov identifier: NCT02848638. ..
  2. Chan K, Alessio A, Johnson G, Vaidya S, Kwan S, Monsky W, et al. Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018;101:358-365 pubmed publisher
    ..Delivered tumor dose can be assessed by PET and significantly impacts treatment response in HCC. ..
  3. Padia S, Johnson G, Horton K, Ingraham C, Kogut M, Kwan S, et al. Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. J Vasc Interv Radiol. 2017;28:777-785.e1 pubmed publisher
    ..064). Segmental radioembolization demonstrates higher complete response rates and local tumor control compared with segmental chemoembolization for HCC, with similar toxicity profiles. Superior progression-free survival was achieved. ..